+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Intracranial Spring Coil Embolization System Market by Technology, Application, End User, Sales Channel, Price Tier - Global Forecast 2025-2030- Product Image
Intracranial Spring Coil Embolization System Market by Technology, Application, End User, Sales Channel, Price Tier - Global Forecast 2025-2030- Product Image
New

Intracranial Spring Coil Embolization System Market by Technology, Application, End User, Sales Channel, Price Tier - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6118037
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The intracranial spring coil embolization system represents a significant innovation in the management of complex neurovascular conditions. By enabling minimally invasive occlusion of pathological vascular structures, these advanced coils have transformed clinical practice for arteriovenous malformations, intracranial aneurysms, and tumor embolization procedures. As patient populations expand and demand for precision interventions grows, this technology has become an indispensable tool in modern neurosurgical and endovascular suites around the world.

This executive summary provides a structured overview of the key forces shaping the intracranial spring coil embolization landscape. It begins with an exploration of pivotal shifts in clinical practice and device technology, followed by an analysis of the evolving tariff environment within the United States. Further sections delve into strategic segmentation insights spanning technology innovations, therapeutic applications, end user channels, distribution pathways, and pricing tiers. Regional dynamics, competitive positioning, actionable recommendations, and the methodological underpinnings of this research are also discussed. Through this narrative, decision-makers will gain a holistic perspective on current market conditions and strategic opportunities.

Exploring the convergence of advanced materials, digital integration, and regulatory evolution driving neurovascular embolization breakthroughs

The intracranial spring coil embolization arena is experiencing multiple transformative shifts that are redefining both clinical and operational paradigms. Advances in material science have led to the introduction of bioactive coated coils with polyglycolic acid and polyglycolic-lactic acid surfaces designed to promote controlled thrombosis, as well as hydrogel coated variants available in prehydrated and expanding formats that enhance occlusion density and reduce recanalization. Alongside these product innovations, digital integration into procedural planning has gained momentum, with three-dimensional imaging platforms and AI-enhanced navigation tools elevating the precision of coil deployment.

Regulatory bodies are simultaneously streamlining approval pathways for devices demonstrating clear safety and efficacy benefits, while also reinforcing post-market surveillance requirements to ensure long-term performance. From a clinical standpoint, multidisciplinary collaboration between neurointerventional radiologists, neurosurgeons, and vascular neurologists is fostering integrated care models that leverage embolization systems as a first-line option. Consequently, this confluence of technological enhancement, regulatory evolution, and collaborative practice is accelerating the adoption of spring coil embolization as a gold standard for complex neurovascular interventions.

Assessing the ripple effects of 2025 United States tariff revisions on supply chain resilience and cost management strategies

The introduction of revised United States tariff schedules in 2025 is exerting a significant influence on the supply chain dynamics for intracranial spring coil embolization systems. Raw materials such as platinum alloys, specialty polymer coatings, and hydrogel precursors are now subject to modified import duties, directly impacting manufacturing cost structures. As a result, device producers are actively reassessing supplier relationships, pursuing alternative sourcing strategies, and negotiating new contractual terms to mitigate margin compression.

Moreover, these tariff changes are influencing distributors and healthcare providers, prompting discussions around pricing adjustments and budget reallocation. Some end users have begun exploring inventory optimization techniques and long-term procurement agreements to shield themselves from potential cost fluctuations. Manufacturers, in turn, are evaluating localized production opportunities to lessen dependency on cross-border shipments and to maintain competitive pricing. In this context, successful navigation of the 2025 tariff landscape will hinge on strategic supply chain resilience, agile operational planning, and collaborative partnerships across the value chain.

Uncovering how technology variants, therapeutic applications, clinical environments, channel strategies, and pricing tiers drive market differentiation

A nuanced segmentation analysis underscores the diversity of factors influencing spring coil embolization adoption and utilization. From a technology standpoint, the market encompasses bare platinum coils with electrolytic and mechanical detachable options, bioactive coated variants leveraging polyglycolic acid and polyglycolic-lactic acid chemistries, and a spectrum of hydrogel coated coils available in both expanding and prehydrated formats. Application-wise, practitioners deploy these systems to address arteriovenous malformation cases involving brain and spinal AVMs, intricate intracranial aneurysms such as dissecting, fusiform, and saccular types, as well as targeted tumor embolization in gliomas and meningiomas.

In terms of end user preferences, ambulatory surgical centers, hospitals, and specialty clinics each exhibit distinct procedural volumes and purchasing criteria that guide product selection and contractual terms. Distribution models split between direct tender arrangements and distributor channels, the latter including evolving e-commerce platforms that streamline order placement and inventory replenishment. Finally, price tier segmentation ranges from economy offerings to standard price devices, with premium price options commanding extra features such as enhanced imaging compatibility or proprietary coating technologies.

Evaluating contrasting regional growth trajectories and strategic enablers across the Americas, EMEA, and Asia Pacific markets

Regional dynamics exert a profound influence on the uptake and utilization of spring coil embolization systems. In the Americas, strong healthcare infrastructure in leading markets has enabled early adoption of advanced coil technologies, supported by collaborative research initiatives and robust reimbursement frameworks. Conversely, emerging economies in this region are demonstrating gradual growth as providers expand access through value-based purchasing models and strategic partnerships with global device manufacturers.

Meanwhile, Europe, Middle East & Africa encompasses a heterogeneous landscape where Western European countries lead with rigorous clinical guidelines and established interventional networks, while Middle Eastern and African markets explore adoption through government-sponsored healthcare programs and private sector investment. In the Asia Pacific, rapid hospital expansion, prioritization of minimally invasive therapies, and growing local manufacturing capabilities are fueling sustained demand. Regional stakeholders are increasingly focused on developing training programs, forging clinician collaborations, and optimizing distribution channels to align with evolving patient and provider needs.

Profiling how leading organizations leverage innovation partnerships, strategic acquisitions, and clinical collaborations to fortify market leadership

Market leaders are driving innovation through a combination of strategic alliances, product portfolio expansion, and targeted acquisitions. Several prominent device manufacturers have invested heavily in research and development to advance coil materials, refine detachment mechanisms, and integrate digital guidance technologies. Collaboration with academic institutions and clinical research organizations has been a cornerstone of validation efforts, enabling robust clinical data that supports regulatory submissions and enhances practitioner confidence.

In parallel, some companies have pursued mergers and acquisitions to augment their product pipelines and geographic reach, thereby strengthening their competitive positioning. Distributor partnerships are also evolving, as companies seek to broaden their market presence through multi-channel distribution agreements. Furthermore, early engagement with key opinion leaders and participation in professional societies have empowered these organizations to shape clinical guidelines and training curricula, ultimately influencing technology adoption curves.

Formulating integrated growth strategies that encompass supply resilience, digital differentiation, and collaborative market access pathways

Industry leaders can enhance their competitive edge by adopting several key strategies. First, forging cross-functional alliances with raw material suppliers and coating technology specialists will ensure timely access to high-performance inputs. Second, investing in digital service platforms that complement coil systems with planning software and post-procedure analytics can differentiate offerings in a crowded marketplace. Third, establishing localized manufacturing or assembly operations in critical regions will help mitigate tariff pressures and improve supply chain agility.

Moreover, companies should prioritize engagement with regulatory authorities to expedite approval pathways and align on post-market surveillance protocols. Clinical training programs co-developed with leading institutions can accelerate practitioner proficiency, while tailored value-based contracting models with payers will support broader reimbursement alignment. By synchronizing these initiatives into an integrated growth plan, organizations can not only navigate present challenges but also position themselves for sustained leadership as the landscape evolves.

Detailing a multi-layered approach combining expert interviews, literature analysis, data triangulation, and competitive benchmarking frameworks

This research combines a rigorous blend of primary and secondary methodologies to ensure comprehensive and reliable insights. Primary interviews were conducted with a cross-section of stakeholders including interventional radiologists, neurosurgeons, procurement managers, and regulatory experts to capture firsthand perspectives on clinical needs, procurement challenges, and approval processes. Secondary research included a systematic review of scientific literature, industry white papers, regulatory filings, and device technical briefs to corroborate emerging trends and technology developments.

Quantitative data points were triangulated using proprietary databases and validated through expert panel workshops, while qualitative analyses were supported by scenario modeling and competitive benchmarking. Analytical frameworks such as SWOT and Porter’s Five Forces were applied to assess market dynamics, supplier power, and competitive intensity. This multi-layered methodology ensures that findings reflect both the nuanced experiences of clinical practitioners and the strategic imperatives of device manufacturers.

Drawing together the strategic imperatives and future outlook that will determine market leadership and technology adoption trajectories

In conclusion, the intracranial spring coil embolization space stands at the intersection of material innovation, digital integration, and evolving clinical protocols. As healthcare systems strive to enhance patient outcomes while managing cost pressures and regulatory scrutiny, this technology offers a compelling solution for complex neurovascular indications. The convergence of advanced polymer and hydrogel coatings, next-generation detachment mechanisms, and AI-enabled procedural planning heralds a new era of precision therapy.

Stakeholders who proactively adapt to tariff shifts, align with emerging reimbursement models, and cultivate strategic partnerships will be best positioned to capitalize on growth opportunities. Ultimately, the capability of organizations to integrate clinical insights, supply chain robustness, and data-driven decision-making will determine their trajectory in this dynamic market. This executive summary has outlined the critical imperatives, and the comprehensive report offers deeper analysis to guide your strategic roadmap.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Technology
    • Bare Platinum Coil
      • Electrolytic Detachable Coil
      • Mechanical Detachable Coil
    • Bioactive Coated Coil
      • Polyglycolic Acid Coated Coil
      • Polyglycolic-Lactic Acid Coated Coil
    • Hydrogel Coated Coil
      • Expanding Hydrogel Coil
      • Prehydrated Hydrogel Coil
  • Application
    • Arteriovenous Malformation
      • Brain Avm
      • Spinal Avm
    • Intracranial Aneurysm
      • Dissecting Aneurysm
      • Fusiform Aneurysm
      • Saccular Aneurysm
    • Tumor Embolization
      • Glioma Embolization
      • Meningioma Embolization
  • End User
    • Ambulatory Surgical Center
    • Hospital
    • Specialty Clinic
  • Sales Channel
    • Direct Tender
    • Distributor
      • E Commerce Platform
  • Price Tier
    • Economy Price
    • Premium Price
    • Standard Price
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:

  • Terumo Corporation
  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson
  • Penumbra, Inc.
  • MicroPort Scientific Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of bioactive coating technologies to enhance coil thrombogenicity and vessel healing
5.2. Impact of pediatric specific coil designs on neurovascular intervention outcomes in children
5.3. Evolution of microcatheter and spring coil compatibility to improve procedural precision and safety
5.4. Rising adoption of detachable coil systems with controlled detachment mechanisms for complex aneurysms
5.5. Influence of real time imaging guided navigation systems on intracranial coil embolization success rates
5.6. Development of resorbable polymer based spring coils to reduce long term foreign body complications
5.7. Competitive landscape shifts driven by strategic partnerships between start ups and large medtech companies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Intracranial Spring Coil Embolization System Market, by Technology
8.1. Introduction
8.2. Bare Platinum Coil
8.2.1. Electrolytic Detachable Coil
8.2.2. Mechanical Detachable Coil
8.3. Bioactive Coated Coil
8.3.1. Polyglycolic Acid Coated Coil
8.3.2. Polyglycolic-Lactic Acid Coated Coil
8.4. Hydrogel Coated Coil
8.4.1. Expanding Hydrogel Coil
8.4.2. Prehydrated Hydrogel Coil
9. Intracranial Spring Coil Embolization System Market, by Application
9.1. Introduction
9.2. Arteriovenous Malformation
9.2.1. Brain Avm
9.2.2. Spinal Avm
9.3. Intracranial Aneurysm
9.3.1. Dissecting Aneurysm
9.3.2. Fusiform Aneurysm
9.3.3. Saccular Aneurysm
9.4. Tumor Embolization
9.4.1. Glioma Embolization
9.4.2. Meningioma Embolization
10. Intracranial Spring Coil Embolization System Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Center
10.3. Hospital
10.4. Specialty Clinic
11. Intracranial Spring Coil Embolization System Market, by Sales Channel
11.1. Introduction
11.2. Direct Tender
11.3. Distributor
11.3.1. E Commerce Platform
12. Intracranial Spring Coil Embolization System Market, by Price Tier
12.1. Introduction
12.2. Economy Price
12.3. Premium Price
12.4. Standard Price
13. Americas Intracranial Spring Coil Embolization System Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Intracranial Spring Coil Embolization System Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Intracranial Spring Coil Embolization System Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Terumo Corporation
16.3.2. Medtronic plc
16.3.3. Stryker Corporation
16.3.4. Johnson & Johnson
16.3.5. Penumbra, Inc.
16.3.6. MicroPort Scientific Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET: RESEARCHAI
FIGURE 26. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET: RESEARCHSTATISTICS
FIGURE 27. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET: RESEARCHCONTACTS
FIGURE 28. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID COATED COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYGLYCOLIC ACID COATED COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYGLYCOLIC-LACTIC ACID COATED COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYGLYCOLIC-LACTIC ACID COATED COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXPANDING HYDROGEL COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY EXPANDING HYDROGEL COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PREHYDRATED HYDROGEL COIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PREHYDRATED HYDROGEL COIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BRAIN AVM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BRAIN AVM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPINAL AVM, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPINAL AVM, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISSECTING ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISSECTING ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FUSIFORM ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR ANEURYSM, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SACCULAR ANEURYSM, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GLIOMA EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GLIOMA EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MENINGIOMA EMBOLIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MENINGIOMA EMBOLIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT TENDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ECONOMY PRICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ECONOMY PRICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PREMIUM PRICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PREMIUM PRICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STANDARD PRICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STANDARD PRICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 141. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 144. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 145. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 146. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 147. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 148. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 149. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 154. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 155. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 162. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 163. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 164. CANADA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 165. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 168. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 169. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 170. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 171. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 172. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 173. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 178. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 179. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 186. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 187. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE PLATINUM COIL, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COATED COIL, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COATED COIL, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATION, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL ANEURYSM, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TUMOR EMBOLIZATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTOR, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRICE TIER, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA INTRACRANIAL SPRING COIL EMBOLIZATION SYS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Intracranial Spring Coil Embolization System market report include:
  • Terumo Corporation
  • Medtronic plc
  • Stryker Corporation
  • Johnson & Johnson
  • Penumbra, Inc.
  • MicroPort Scientific Corporation

Related Topics

Related Reports

Peripheral Coil Embolization System Market by Product Type, Indication, End User, Distribution Channel, Material, Technology, Coil Size - Global Forecast 2025-2030 - Product Image

Peripheral Coil Embolization System Market by Product Type, Indication, End User, Distribution Channel, Material, Technology, Coil Size - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Embolization Coils - Global Strategic Business Report - Product Image

Embolization Coils - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Detachable Coil Embolization System Market by End User (Ambulatory Surgery Centers, Hospitals), Delivery Mechanism (Electrodetachable, Mechanical Detachable), Configuration, Application, Coil Type - Global Forecast 2025-2030 - Product Image

Detachable Coil Embolization System Market by End User (Ambulatory Surgery Centers, Hospitals), Delivery Mechanism (Electrodetachable, Mechanical Detachable), Configuration, Application, Coil Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application - Product Image

North America Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

  • Report
  • 107 Pages
  • North America
From
North America Embolization Coils Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Product Image

North America Embolization Coils Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

  • Report
  • 139 Pages
  • North America
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.